Pharmacist says common condition is on rise 'but you can slash risk'
A senior pharmacist has explained the key warning signs of diabetes, as she said it was on the rise in the UK. With one in ...
Warning of diabetes signs as 'millions' of Brits don't know they have it
Up to one in five adults in the UK could have prediabetes, a condition that causes higher than normal blood sugars and ...
One fifth of UK adults have diabetes or pre-diabetes in 'hidden health crisis' - check if you're one
According to new research by Diabetes UK, around 1.3 million people are suffering with undiagnosed type 2 diabetes.
A ‘hidden health crisis’ in the UK is now 'affecting 12 million Brits'
A worrying one in five adults are thought to be living with high blood sugar levels, with millions completely unaware of it ...
UK's 'hidden health crisis' now affecting 12million Brits is gateway to strokes and heart attacks
Diabetes UK analysis suggests that more than 12million Brits are living with dangerously high blood sugar levels, which can lead to serious health complications ...
Diabetes warning as high blood sugar condition or prediabetes affects one in five Brits
Worrying findings suggest 12million Brits are living with dangerously high blood sugar levels, as Diabetes UK warns of a ...
Bristol Post6d
Millions have diabetes without knowing - how to tell if it's you
One in five adults in the UK is thought to be living with diabetes or prediabetes, which causes higher than normal blood ...
Teladoc Health to Acquire Catapult Health, Advancing Integrated Care Strategy
Building on its over 93-million-member base, Teladoc Health’s acquisition of Catapult Health supports the company’s integrated care segment strategy, discussed most recently during the company’s ...
researchbysubject.bucknell.edu14d
Episode 87: Pre-College Programs
Websites, brochures and social media can only tell you so much about what a college is like. While visiting in person is an excellent way to get a feel for campus life, there are even more immersive ...
CNN14d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...